PTC Therapeutics to Participate at Upcoming Investor Conferences
PTC Therapeutics (NASDAQ: PTCT) has announced its participation in four major healthcare investor conferences in May and June 2025. The schedule includes:
- Bank of America Securities Healthcare Conference on May 13 at 1:00 p.m. ET
- RBC Capital Markets Global Healthcare Conference on May 20 at 2:05 p.m. ET
- William Blair 45th Annual Growth Stock Conference on June 3 at 10:20 a.m. ET
- Goldman Sachs 46th Annual Global Healthcare Conference on June 10 at 9:20 a.m. ET
All presentations will be available via live webcast on PTC's investor relations website and will remain accessible for 30 days after each event. Viewers are advised to connect several minutes before the start time.
PTC Therapeutics (NASDAQ: PTCT) ha annunciato la sua partecipazione a quattro importanti conferenze per investitori nel settore sanitario previste per maggio e giugno 2025. Il calendario include:
- Bank of America Securities Healthcare Conference il 13 maggio alle 13:00 ET
- RBC Capital Markets Global Healthcare Conference il 20 maggio alle 14:05 ET
- William Blair 45ª Annual Growth Stock Conference il 3 giugno alle 10:20 ET
- Goldman Sachs 46ª Annual Global Healthcare Conference il 10 giugno alle 9:20 ET
Tutte le presentazioni saranno disponibili tramite webcast in diretta sul sito web delle relazioni con gli investitori di PTC e resteranno accessibili per 30 giorni dopo ogni evento. Si consiglia agli spettatori di collegarsi qualche minuto prima dell’inizio.
PTC Therapeutics (NASDAQ: PTCT) ha anunciado su participación en cuatro importantes conferencias para inversores del sector sanitario en mayo y junio de 2025. El calendario incluye:
- Bank of America Securities Healthcare Conference el 13 de mayo a la 1:00 p.m. ET
- RBC Capital Markets Global Healthcare Conference el 20 de mayo a las 2:05 p.m. ET
- William Blair 45ª Conferencia Anual Growth Stock el 3 de junio a las 10:20 a.m. ET
- Goldman Sachs 46ª Conferencia Anual Global Healthcare el 10 de junio a las 9:20 a.m. ET
Todas las presentaciones estarán disponibles mediante transmisión en vivo en el sitio web de relaciones con inversores de PTC y permanecerán accesibles durante 30 días después de cada evento. Se recomienda a los espectadores conectarse varios minutos antes del inicio.
PTC Therapeutics (NASDAQ: PTCT)는 2025년 5월과 6월에 열리는 주요 헬스케어 투자자 컨퍼런스 네 곳에 참가할 예정임을 발표했습니다. 일정은 다음과 같습니다:
- 5월 13일 오후 1시(동부시간) Bank of America Securities Healthcare Conference
- 5월 20일 오후 2시 5분(동부시간) RBC Capital Markets Global Healthcare Conference
- 6월 3일 오전 10시 20분(동부시간) William Blair 45회 연례 Growth Stock Conference
- 6월 10일 오전 9시 20분(동부시간) Goldman Sachs 46회 연례 Global Healthcare Conference
모든 발표는 PTC 투자자 관계 웹사이트에서 라이브 웹캐스트로 제공되며, 각 행사 후 30일간 시청할 수 있습니다. 시청자분들은 시작 시간 몇 분 전에 접속하시길 권장합니다.
PTC Therapeutics (NASDAQ : PTCT) a annoncé sa participation à quatre grandes conférences pour investisseurs dans le secteur de la santé en mai et juin 2025. Le calendrier comprend :
- Bank of America Securities Healthcare Conference le 13 mai à 13h00 ET
- RBC Capital Markets Global Healthcare Conference le 20 mai à 14h05 ET
- William Blair 45e conférence annuelle Growth Stock le 3 juin à 10h20 ET
- Goldman Sachs 46e conférence annuelle Global Healthcare le 10 juin à 9h20 ET
Toutes les présentations seront accessibles via webdiffusion en direct sur le site des relations investisseurs de PTC et resteront disponibles pendant 30 jours après chaque événement. Il est conseillé aux spectateurs de se connecter quelques minutes avant le début.
PTC Therapeutics (NASDAQ: PTCT) hat seine Teilnahme an vier bedeutenden Investorenkonferenzen im Gesundheitswesen im Mai und Juni 2025 angekündigt. Der Zeitplan umfasst:
- Bank of America Securities Healthcare Conference am 13. Mai um 13:00 Uhr ET
- RBC Capital Markets Global Healthcare Conference am 20. Mai um 14:05 Uhr ET
- William Blair 45. Jahrestag Growth Stock Conference am 3. Juni um 10:20 Uhr ET
- Goldman Sachs 46. Jahrestag Global Healthcare Conference am 10. Juni um 9:20 Uhr ET
Alle Präsentationen werden über einen Live-Webcast auf der Investor-Relations-Website von PTC verfügbar sein und sind 30 Tage nach jeder Veranstaltung abrufbar. Zuschauer werden gebeten, einige Minuten vor Beginn online zu sein.
- None.
- None.
Bank of America Securities 2025 Health Care Conference
Tuesday, May 13 at 10:00 a.m. PT / 1:00 p.m. ET
RBC Capital Markets Global Healthcare Conference 2025
Tuesday, May 20 at 2:05 p.m. ET
William Blair 45th Annual Growth Stock Conference 2025
Tuesday, June 3 at 9:20 a.m. CT / 10:20 a.m. ET
Goldman Sachs 46th Annual Global Healthcare Conference 2025
Tuesday, June 10 at 9:20 a.m. ET
The presentations will be webcast live on the Events and Presentations page under the Investor section of PTC Therapeutics' website at https://ir.ptcbio.com/events-presentations and will be archived for 30 days following the presentation. It is recommended that users connect to PTC's website several minutes prior to the start of the webcast to ensure a timely connection.
About PTC Therapeutics, Inc.
PTC is a global biopharmaceutical company focused on the discovery, development and commercialization of clinically differentiated medicines that provide benefits to children and adults living with rare disorders. PTC's ability to globally commercialize products is the foundation that drives investment in a robust and diversified pipeline of transformative medicines and our mission to provide access to best-in-class treatments for patients who have an unmet medical need. The company's strategy is to leverage its strong scientific expertise and global commercial infrastructure to maximize value for its patients and other stakeholders. To learn more about PTC, please visit us at www.ptcbio.com and follow us on Facebook, X, and LinkedIn.
For More Information:
Investors:
Ellen Cavaleri
+1 (615) 618-6228
ecavaleri@ptcbio.com
Media:
Jeanine Clemente
+1 (908) 912-9406
jclemente@ptcbio.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/ptc-therapeutics-to-participate-at-upcoming-investor-conferences-302436290.html
SOURCE PTC Therapeutics, Inc.